Second coming: the re-emergence and modernization of immunotherapy by vaccines as a component of leprosy control

Future Microbiol. 2018 Oct:13:1449-1451. doi: 10.2217/fmb-2018-0186. Epub 2018 Oct 12.

Authors

Malcolm S Duthie¹, Corey Casper¹, Steven G Reed¹

Affiliation

¹ From the Infectious Disease Research Institute, 1616 Eastlake Ave E, Suite 400, Seattle, WA 98102, USA.

PMID: 30311780
DOI: 10.2217/fmb-2018-0186

No abstract available

Keywords: adjuvant; attenuated; inflammatory; leprosy; protein.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Adjuvants, Immunologic / administration & dosage
Adjuvants, Immunologic / therapeutic use
Adult
Animals
Bacterial Vaccines / administration & dosage
Bacterial Vaccines / immunology*
Bacterial Vaccines / therapeutic use
Child
Communicable Diseases, Emerging / drug therapy
Communicable Diseases, Emerging / immunology
Communicable Diseases, Emerging / prevention & control
Communicable Diseases, Emerging / therapy*
Disease Models, Animal
Humans
Immunotherapy / methods*
Leprostatic Agents / administration & dosage
Leprostatic Agents / therapeutic use
Leprosy / drug therapy
Leprosy / immunology
Leprosy / prevention & control
Leprosy / therapy*
Mycobacterium leprae / drug effects
Mycobacterium leprae / immunology
Neglected Diseases / drug therapy
Neglected Diseases / immunology
Neglected Diseases / prevention & control
Neglected Diseases / therapy*
Post-Exposure Prophylaxis
Rifampin / administration & dosage
Rifampin / therapeutic use
Vaccines, Synthetic / administration & dosage
Vaccines, Synthetic / immunology
Vaccines, Synthetic / therapeutic use

Substances

Adjuvants, Immunologic
Bacterial Vaccines
Leprostatic Agents
Vaccines, Synthetic
Rifampin